Quantitative Systematic Strategies LLC Myovant Sciences Ltd. Transaction History

Quantitative Systematic Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$13.8 - $27.62 $164,440 - $329,119	-11,916 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$14.05 - $22.6 $4,299 - $6,915	-306 Reduced 2.5%	11,916 $167,000
Q2 2020 Aug 04, 2020	SELL	$7.34 - $20.84 $11,354 - $32,239	-1,547 Reduced 11.24%	12,222 $252,000
Q1 2020 May 06, 2020	SELL	$6.55 - $14.76 $288 - $649	-44 Reduced 0.32%	13,769 $104,000
Q4 2019 Feb 11, 2020	BUY	$4.2 - $19.21 $58,014 - $265,347	13,813 New	13,813 $214,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.